Serious adverse events up to week 12 · Patients with active Crohn's disease
Three infusions of natalizumab (300 mg) showed no clear difference in serious adverse events up to week 12 compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events up to week 10 · Participants with active Crohn's disease despite current treatment with infliximab
Three infusions of natalizumab (300 mg) and two infusions of… showed no clear difference in serious adverse events up to week 10 compared with placebo and two infusions of infliximab (low certainty).
1 finding from 1 review
Serious adverse events up to week 12 · Patients with active Crohn's disease
One infusion of natalizumab (300 mg or 3 mg/kg) showed no clear difference in serious adverse events up to week 12 compared with placebo (low certainty).
1 finding from 1 review
Adverse events (at 4, 6 or 12 weeks) · adults with insomnia
Tricyclic antidepressants showed no clear difference in adverse events (at 4, 6 or 12 weeks) compared with placebo (low certainty).
1 finding from 1 review
Serious adverse events (3 to 4 weeks · children with stable wrist fracture, predominantly buckle (torus) fracturesa
1 finding from 1 review
Risk of adverse events: Loose stools · participants at risk of high altitude illness
Magnesium citrate may leads to higher risk of adverse events: Loose stools compared with placebo (low certainty).
1 finding from 1 review
Adverse events during treatment period · people with glaucoma receiving LTP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events during treatment period · people with glaucoma receiving LTP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events during treatment period · people with glaucoma receiving LTP
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events: death ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events Analysis 11.2 · patients with rheumatoid arthritis
Rituximab (2 x 1000 mg) plus methotrexate showed no clear difference in serious adverse events Analysis 11.2 compared with methotrexate monotherapy (moderate certainty).
1 finding from 1 review
Toxicity ‐ early adverse events G3/4 · people with resectable stage II and III rectal cancer undergoing preoperative chemoradiation followed by surgery
Combination chemotherapy probably leads to higher toxicity ‐ early adverse events G3/4 compared with single‐agent chemotherapy (moderate certainty).
1 finding from 1 review
Adverse events considered non‐serious · participants with unresectable hepatocellular carcinoma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
Summary of findings ‐ Erector spinae plane block showed no clear difference in rates of block‐related adverse events compared with serratus anterior plane block (low certainty).
1 finding from 1 review
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
It is very uncertain whether summary of findings ‐ Erector spinae plane block changes rates of block‐related adverse events compared with intercostal nerve block (very low certainty).
1 finding from 1 review
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
1 finding from 1 review
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
Summary of findings ‐ Erector spinae plane block showed no clear difference in rates of block‐related adverse events compared with no block (low certainty).
1 finding from 1 review
Rates of block‐related adverse events · adults undergoing surgery with general anaesthesia
Summary of findings ‐ Erector spinae plane block showed no clear difference in rates of block‐related adverse events compared with placebo block (low certainty).
1 finding from 1 review